P. Abeysinghe

Docetaxel‐induced interstitial lung disease among patients with breast cancer: a case series and review of literature

A. Rathnapala, Sanjeewa Malinda Hettiarachchi, Dilanka Thilakaratne, 2021, Respirology case reports.

Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka

R. Lalloo, M. Hjermstad, P. Jayasekara, 2022, BMC oral health.

Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival.

Nuradh Joseph, N. Jeyakumaran, P. Abeysinghe, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Health related quality of life of oral cancer patients who receive radiotherapy with or without chemotherapy in a tertiary referral centre in Sri Lanka- A prospective study

R. Lalloo, P. Jayasekara, P. Abeysinghe, 2022, medRxiv.

Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial.

R. Holloway, R. Fraser, R. Botten, 2006, International journal of radiation oncology, biology, physics.

Wisely Frugal: Ensuring sustainable funding for novel cancer therapeutics using cost-effectiveness thresholds in resource limited settings

N. Jeyakumaran, P. Abeysinghe, V. Bamunuarachchi, 2023, medRxiv.

Oral health related quality of life of oral cancer patients treated with radiotherapy alone or with chemotherapy in a tertiary referral centre in Sri Lanka

R. Lalloo, P. Jayasekara, P. Abeysinghe, 2023, BMC Oral Health.

Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMT

B. Ko, J. Sim, A. Srivastava, 2022, Blood cell therapy.

Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology

Hong-Gyun Wu, E. Tharavichitkul, H. Aoyama, 2023, JCO global oncology.